Vanguard Group Inc Ptc Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,973,771 shares of PTCT stock, worth $337 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,973,771
Previous 9,369,014
4.22%
Holding current value
$337 Million
Previous $273 Million
0.69%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding PTCT
# of Institutions
215Shares Held
79.2MCall Options Held
122KPut Options Held
212K-
Wellington Management Group LLP Boston, MA8.21MShares$308 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$292 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$278 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$262 Million2.77% of portfolio
-
Cowen And Company, LLC3.76MShares$141 Million2.94% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.69B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...